Potential Use of Cyclodextrins as Drug Carriers and Active Pharmaceutical Ingredients

被引：51
|
作者：
Arima, Hidetoshi [1 ,2 ]
Motoyama, Keiichi [1 ]
Higashi, Taishi [1 ]
机构：
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
[2] Kumamoto Univ, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Program Leading Grad Sch, Chuo Ku, 5-1 Oehonmachi, Kumamoto 8620973, Japan
来源：
CHEMICAL & PHARMACEUTICAL BULLETIN | 2017年 / 65卷 / 04期
关键词：
cyclodextrin (CyD); drug delivery system (DDS); active pharmaceutical ingredient; non-viral vector; supramolecule; METHYL-BETA-CYCLODEXTRIN; TERNARY INCLUSION COMPLEX; SUSTAINED-RELEASE SYSTEM; PICK-C-DISEASE; IN-VITRO; ALPHA-CYCLODEXTRIN; PEGYLATED INSULIN; BIOCLEAVABLE POLYROTAXANES; FULMINANT-HEPATITIS; GAMMA-CYCLODEXTRINS;
D O I：
10.1248/cpb.c16-00779
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Cyclodextrins (CyDs) are extensively used in various fields, and especially have been widely utilized as pharmaceutical excipients and drug carriers in the pharmaceutical field. Owing to the multi -functional and biocompatible characteristics, CyDs can improve the undesirable properties of drug molecules. This review outlines the current application of CyDs in pharmaceutical formulations, focusing on their use as CyD-based drug carriers for several kinds of drugs. Additionally, CyDs have great potential as active pharmaceutical ingredients against various diseases with few side effects.
引用
收藏
页码：341 / 348
页数：8
相关论文
共 50 条
  • [41] Medicated ocular bandages and corneal health: potential excipients and active pharmaceutical ingredients
    Zidan, Ghada
    Rupenthal, Ilva D.
    Greene, Carol
    Seyfoddin, Ali
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (03) : 255 - 260
  • [42] Nanostructured lipid carriers: A prospective dermal drug delivery system for natural active ingredients
    Fitriani, Endang Wahyu
    Avanti, Christina
    Rosana, Yeva
    Surini, Silvia
    PHARMACIA, 2024, 71 : 1 - 15
  • [43] Olefin metathesis: a versatile synthetic tool for use in preparation of Active Pharmaceutical Ingredients
    Olszewski, Tomasz K.
    Figlus, Marek
    Bieniek, Michal
    CHIMICA OGGI-CHEMISTRY TODAY, 2014, 32 (05) : 22 - +
  • [44] Formulation and Manufacture of Pharmaceuticals by Fluidized-Bed Impregnation of Active Pharmaceutical Ingredients onto Porous Carriers
    Grigorov, Plamen I.
    Glasser, Benjamin J.
    Muzzio, Fernando J.
    AICHE JOURNAL, 2013, 59 (12) : 4538 - 4552
  • [45] Preparation of Amorphous Solid Dispersions by Cryomilling: Chemical and Physical Concerns Related to Active Pharmaceutical Ingredients and Carriers
    Pas, Timothy
    Bergonzi, Alessandra
    Michiels, Emiel
    Rousseau, Frederic
    Schymkowitz, Joost
    Koekoekx, Robin
    Clasen, Christian
    Vergauwen, Bjorn
    Van den Mooter, Guy
    MOLECULAR PHARMACEUTICS, 2020, 17 (03) : 1001 - 1013
  • [46] Qualification and validation in the manufacture of active pharmaceutical ingredients and pharmaceutical products
    Metzger, K
    PHARMAZEUTISCHE INDUSTRIE, 1999, 61 (10): : 945 - 952
  • [47] Handling of highly active pharmaceutical ingredients and intermediates in the pharmaceutical industry
    Miedinger, David
    SAFETY AND HEALTH AT WORK, 2022, 13 : S39 - S39
  • [48] An Overview of HPLC Methods for the Enantiomer Separation of Active Pharmaceutical Ingredients in Bulk and Drug Formulations
    Christodoulou, Eleni A.
    CURRENT ORGANIC CHEMISTRY, 2010, 14 (19) : 2337 - 2347
  • [49] Deep eutectic solvents comprising active pharmaceutical ingredients in the development of drug delivery systems
    Pedro, Sonia N.
    Freire, Mara G.
    Freire, Carmen S. R.
    Silvestre, Armando J. D.
    EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (05) : 497 - 506
  • [50] Analytical approaches for the detection of epoxides and hydroperoxides in active pharmaceutical ingredients, drug products and herbals
    Elder, D. P.
    Snodin, D.
    Teasdale, A.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2010, 51 (05) : 1015 - 1023
12345